44
Views
82
CrossRef citations to date
0
Altmetric
Article

Abnormal Heart Development and Lung Remodeling in Mice Lacking the Hypoxia-Inducible Factor-Related Basic Helix-Loop-Helix PAS Protein NEPAS

, , , , , , , , , , & show all
Pages 1285-1297 | Received 25 Jul 2007, Accepted 20 Nov 2007, Published online: 27 Mar 2023

REFERENCES

  • Asikainen, T. M., A. Ahmad, B. K. Schneider, W. B. Ho, M. Arend, M. Brenner, V. Gunzler, and C. W. White. 2005. Stimulation of HIF-1α, HIF-2α, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells. Free Radic. Biol. Med. 38:1002–1013.
  • Brusselmans, K., V. Compernolle, M. Tjwa, M. S. Wiesener, P. H. Maxwell, D. Collen, and P. Carmeliet. 2003. Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J. Clin. Investig. 111:1519–1527.
  • Burri, P. H. 1984. Fetal and postnatal development of the lung. Annu. Rev. Physiol. 46:617–628.
  • Compernolle, V., K. Brusselmans, T. Acker, P. Hoet, M. Tjwa, H. Beck, S. Plaisance, Y. Dor, E. Keshet, F. Lupu, B. Nemery, M. Dewerchin, P. Van Veldhoven, K. Plate, L. Moons, D. Collen, and P. Carmeliet. 2002. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fetal respiratory distress in premature mice. Nat. Med. 8:702–710.
  • Edelberg, J. M., W. C. Aird, W. Wu, H. Rayburn, W. S. Mamuya, M. Mercola, and R. D. Rosenberg. 1998. PDGF mediates cardiac microvascular communication. J. Clin. Investig. 102:837–843.
  • Ema, M., S. Taya, N. Yokotani, K. Sogawa, Y. Matsuda, and Y. Fujii-Kuriyama. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 94:4273–4278.
  • Endo, A., M. Ayusawa, M. Minato, M. Takada, S. Takahashi, and K. Harada. 2001. Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of newborn. Eur. J. Pediatr. 160:217–222.
  • Epstein, A. C. R., J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, M. Mukherji, E. Metzen, M. I. Wilson, A. Dhanda, Y.-M. Tian, N. Masson. D. L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P. H. Maxwell, C. W. Pugh, C. J. Schofield, and P. J. Ratcliffe. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43–54.
  • Genbacev, O., A. Krtolica, W. Kaelin, and S. J. Fisher. 2001. Human cytotrophoblast expression of the von Hippel-Lindau protein is downregulated during uterine invasion in situ and upregulated by hypoxia in vitro. Dev. Biol. 233:526–536.
  • Gu, Y. Z., S. M. Moran, J. B. Hogenesch, L. Wartman, and C. A. Bradfield. 1998. Molecular characterization and chromosomal localization of third α-class hypoxia inducible factor subunit, HIF-3α. Gene Expr. 7:205–213.
  • Hara, S., J. Hamada, C. Kobayashi, Y. Kondo, and N. Imura. 2001. Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: suppression of HIF-mediated gene expression by HIF-3α. Biochem. Biophys. Res. Commun. 287:808–813.
  • Huang, L. E., J. Gu, M. Schau, and H. F. Bunn. 1998. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95:7987–7992.
  • Iyer, N. V., L. E. Kotch, F. Agani, S. W. Leung, E. Laughner, R. H. Wenger, M. Gassmann, J. D. Gearhart, A. M. Lawler, A. Y. Yu, and G. L. Semenza. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12:149–162.
  • Kakinuma, Y., T. Miyauchi, K. Yuki, N. Murakoshi, K. Goto, and I. Yamaguchi. 2001. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1α induced for impaired myocardial energy metabolism. Circulation 103:2387–2394.
  • Kumar, P., N. J. Kazzi, and S. Shankaran. 1996. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am. J. Perinatol. 13:335–341.
  • Kuwabara, K., S. Ogawa, M. Matsumoto, S. Koga, M. Clauss, D. J. Pinsky, P. Lyn, J. Leavy, L. Witte, J. Joseph-Silverstein, M. B. Furie, G. Torcia, F. Cozzolino, T. Kamada, and D. M. Stern. 1995. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. USA 92:4606–4610.
  • Lee, Y. M., C.-H. Jeong, S.-Y. Koo, M. J. Son, H. S. Song, S.-K. Bae, J. A. Raleigh, H.-Y. Chung, M.-A. Yoo, and K.-W. Kim. 2001. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev. Dyn. 220:175–186.
  • Makino, Y., A. Kanopka, W. J. Wilson, H. Tanaka, and L. Poellinger. 2002. Inhibitory PAS domain protein (IPAS) is hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus. J. Biol. Chem. 277:32405–32408.
  • Makino, Y., R. Cao, K. Svensson, G. Bertilsson, M. Asman, H. Tanaka, Y. Cao, A. Berkenstam, and L. Poellinger. 2001. Inhibitory PAS domain protein is negative regulator of hypoxia-inducible gene expression. Nature 414:550–554.
  • Maulik, N., and D. K. Das. 2002. Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. J. Cell. Mol. Med. 6:13–24.
  • Maxwell, P. H., M. S. Wiesener, G.-W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, P. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275.
  • Maynard, M. A., H. Qi, J. Chung, E. H. Lee, Y. Kondo, S. Hara, R. C. Conaway, J. W. Conaway, and M. Ohh. 2003. Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278:11032–11040.
  • Morita, M., O. Ohneda, T. Yamashita, S. Takahashi, N. Suzuki, O. Nakajima, S. Kawauchi, M. Ema, S. Shibahara, T. Udono, K. Tomita, M. Tamai, K. Sogawa, M. Yamamoto, and Y. Fujii-Kuriyama. 2003. HLF/HIF-2α is key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22:1134–1146.
  • Ohneda, O., C. Fennie, Z. Zheng, C. Donahue, H. La, R. Villacorta, B. Cairns, and L. A. Laskey. 1998. Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad-mesonephros region-derived endothelium. Blood 92:908–919.
  • Peng, J., L. Zhang, L. Drysdale, and G.-H. Fong. 2000. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. USA 97:8386–8391.
  • Rose, F., F. Grimminger, J. Appel, M. Heller, V. Pies, N. Weissmann, L. Fink, S. Schmidt, S. Krick, G. Camenish, M. Gassmann, W. Seeger, and J. Hanze. 2002. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. FASEB J. 16:1660–1661.
  • Rosenberg, A. A., J. Kennaugh, S. L. Koppenhafer, M. Loomis, B. A. Chatfield, and S. H. Abman. 1993. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J. Pediatr. 123:109–114.
  • Schiffrin, E. L. 2005. Vascular endothelin in hypertension. Vasc. Pharmacol. 43:19–29.
  • Semenza, G. L. 2004. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 96:1173–1177.
  • Shimoda, L. A., D. J. Manalo, J. S. Sham, G. L. Semenza, and J. T. Sylvester. 2001. Partial HIF-1 alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L202–L208.
  • Sugihara, C. 2001. Treatment of persistent pulmonary hypertension of the newborn. J. Pediatr. 77:S17–S24.
  • Tanaka, Y., M. Nagai, T. Date, T. Okada, Y. Abe, S. Seki, M. Taniguchi, I. Taniguchi, and S. Mochizuki. 2004. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats. Hypertens. Res. 27:865–875.
  • Tian, H., R. E. Hammer, A. M. Matsumoto, D. W. Russell, and S. L. McKnight. 1998. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12:3320–3324.
  • Wang, G. L., B.-H. Jiang, E. A. Rue, and G. L. Semenza. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92:5510–5514.
  • Wang, X., H. Osinska, G. W. Dorn II, M. Niemen, J. N. Lorenz, A. M. Gerdes, S. Witt, T. Kimball, J. Gulick, and J. Robbins. 2001. Mouse model of desmin-related cardiomyopathy. Circulation 103:2402–2407.
  • Weinberger, B., K. Weiss, D. E. Heck, D. L. Laskin, and J. D. Laskin. 2001. Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol. Ther. 89:67–79.
  • Wenger, R. H., and M. Gassman. 1997. Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem. 378:609–616.
  • Zheng, X., J. L. Ruas, R. Cao, F. A. Salmons, Y. Cao, L. Poellinger, and T. Pereira. 2006. Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization. Mol. Cell. Biol. 26:4628–4641.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.